Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 200

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 200
---
        1,000 |                          1 |                                        2022 |                2025 |                                 2 |                          |                |                                        | ò                     | Í                 |                     |
| DIRECTORSREPRESENTINGEMPLOYEES | Wolfgang Laux           |    |  57 |              |               Seebiography |                                           1 |                2021 |                              2025 |                        3 |                |                                        | ò                     |                   |                     |
| Yann Tran                      |                         | 59 |     | Seebiography |                          1 |                                        2021 |                2025 |                                 3 |                          |                |                                        |                       |                   |                     |

Í Chair ò Member (a) Includes all directorships held in listed companies. The office held within Sanofi is included. (b) Frédéric Oudéa was initially appointed as a non-voting director by the Board on September 2, 2022, and then appointed as a director by the Annual General Meeting on May 25, 2023. (c) Includes shares that vested in May 2023 and May 2024 under the equity-based compensation plans of April 28, 2020 and April 30, 2021. (d) Jean-Paul Kress was co-opted as a director by the Board of Directors meeting of December 19, 2024 with effect from January 1, 2025, to replace Gilles Schnepp who resigned from office effective December 31, 2024. (e) Patrick Kron was appointed as Chair of the Appointments, Governance & CSR Committee with effect from January 1, 2025 on an interim basis until the close of the 2025 AGM following Gilles Schnepp's registration as a director.

| 96 | SANOFIFORM 20-F2024 |

| PART I                                             |
| ITEM 6. Directors, Senior Management and Employees |

Director who held office during the year ended December 31, 2024

|                   |     | Age | Nationality | Number of Sanofishares held | Number ofdirectorships inlisted companies(a) | Date first appointed | End of term ofoffice | Years of service onBoard | Audit Committee | Appointments,Governance & CSRCommittee | CompensationCommittee | StrategyCommittee | ScientificCommittee |
| Gilles Schnepp(a) |     |  66 |             |                       1,